Larvol Delta - ENLIVEN-Study-Evaluating-the-Safety-Efficacy-and-Tolerability-of-BIO89100-in-Subjects-With-Biopsyconfirmed-Nonalcoholic-Steatohepatitis-NASH

pegozafermin (BIO89-100) - 89Bio

http://clinicaltrials.gov/ct2/show/NCT04929483

Feb 7, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next